TORONTO, ON (August 10, 2015) — Toronto-based law firm Aird & Berlis LLP (A&B) has become the sponsoring legal partner to the University of Toronto Early-Stage Technology Program (UTEST).
This partnership was covered in TechVibes, Law Times and the Financial Post's Legal Post blog.
UTEST is a 12-month incubation and acceleration program co-managed by the University of Toronto (U of T) and MaRS Innovation that allows selected U of T-affiliated early-stage startup companies to incorporate, use office space, receive mentorship and access $30,000 ...
On Tuesday, July 28, 2015, the federal government announced a $114-million grant to cement the University of Toronto's position as one of the world's leading centres for the design and manufacture of cells, tissues and organs to treat degenerative disease.
This announcement was covered in The Globe & Mail and Lab Products News, and by CBC.ca, CTV News and Global TV. MaRS Innovation was specifically mentioned as a commercialization partner in the Toronto Star's coverage.
As the university's commercialization agent, MaRS Innovation welcomes this ...
Former Orlando Magic player new innovation director for basketball smartwatch app
This article is republished with the kind permission of Brianna Goldberg and our friends at U of T News.
UTEST company Onyx Motion has partnered with NBA shooting guard Ben Gordon to raise the calibre of digital basketball coaching offered by the company’s first-of-its-kind technology, a smartwatch app that offers on-court skills guidance. The company announced Gordon’s role in helping to further develop the app, called Swish, on July 8 when launching ...
TORONTO (July 9, 2015) — Xagenic, a molecular diagnostics company developing the lab-free Xagenic X1™ platform for point-of-care use, today announced that it has raised $15 million (CAD). Each of the company's Series B investors has participated in this financing, including Domain Associates, CTI Life Sciences, BDC Capital and the Ontario Capital Growth Corporation.
PE Hub, Cantech Letter, Genome Web, Fierce Medical Devices and the Wall Street Journal's Venture Capital Dispatch blog covered this announcement.
In June, Xagenic also announced it has acquired ...
The Medical Sciences Proof-of-Principle (MSc PoP) program, administered by Ontario Centres of Excellence on behalf of Ontario's Ministry of Research & Innovation, is a province-wide initiative for which MaRS Innovation accepts applications from our 15 member institutions.
MaRS Innovation is currently recruiting applications for the July 30, 2015 August 27, 2015 (2 pm) deadline; for submissions to be considered via MI, paperwork must be in byAugust 24, 2015 (4 pm).
We've also learned there will be a second call for MScPoP applications in ...
XOR Labs Toronto, a Canadian company spun off from the University Health Network in partnership with MaRS Innovation, was profiled by VICE's Motherboard for their technology.
They've developed an advanced and unique system that enables the assessment and repair of previously unusable donor lungs, which may facilitate more transplants for patients like Hélène Campbell, who famously danced on The Ellen Degeneres Show following a successful operation that included technology developed by the company's founders.
Here's an excerpt from Jordan Pearson's article, "The Future ...
Ministry of Research & Innovation joins founding partners University of Toronto and Janssen Inc., and new partners Evotec AG, MaRS Innovation and Ontario Centres of Excellence, to advance treatments for neurological disorders and develop early-stage biotech companies
TORONTO and PHILADELPHIA (June 16, 2015)— Toronto’s neuroscience efforts to find new drugs to treat and manage brain disorders — specifically, mood disorders and Alzheimer's disease — took another step forward as the Government of Ontario’s Ministry of Research and Innovation announced a $1 million ...
Fanny Sie, MaRS Innovation's head of imaging technologies, was quoted in Tanya Powley's article, "Printing whole organs remains a long way off," for the U.K.'s Financial Times on June 11, 2015, regarding the technology's potential to transform existing healthcare practices.
MI does wish to note that the article inaccurately attributes the PrintAlive device's development to MaRS Innovation; MI is working with the University of Toronto inventing team, led by Dr. Axel Gunther, to commercialize the device.
Here's a short excerpt:
Bioprinting could save pharmaceutical ...